Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)
Ove Andersen
ClinicalTrials.gov, 2025-01-15
Plain English summary
This clinical study investigated the use of Sativex (nabiximols) to stimulate appetite and evaluated its pharmacokinetics in older hospitalised patients suffering from malnutrition. The research aimed to determine how aging, body composition, and organ function affect the processing of cannabinoid-based medications.
Outcome
The trial is completed, but specific clinical outcomes and efficacy results are not reported in this registry record.
Abstract
Conditions: Malnutrition, Anorexia, Cannabis, Aging, Emergency Service, Hospital, Renal Function, Pharmacokinetics Status: COMPLETED Enrolment: 169 Malnutrition and inappropriate prescribing of renally excreted drugs are common among older persons and are associated with severe consequences such as complicated courses of treatment, mortality, and reduced quality of life. The overall purpose of CanPan is to optimize treatment of older persons with malnutrition with a focus on appetite stimulation and optimized prescribing of renal risk drugs. The CanPan trial consists of two sub-studies. Substudy 1 will provide knowledge on appetite and appetite stimulation and together, sub study 1 and 2 will offer unique knowledge on how body composition, renal function and biomarkers of organ function influence pharmacokinetics for a highly lipophilic (Sativex®) and hydrophilic (Hexamycin®) drug in older medical patients with malnutrition.
Conditions
Cannabinoids
Body systems
Summary generated automatically from the published abstract for educational purposes. Not medical advice. Always consult the original source and a qualified clinician.